Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-018539
Filing Date
2021-03-08
Accepted
2021-03-08 16:14:39
Documents
2
Period of Report
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7650
2 POA DOCUMENT poa.txt EX-24.3_971029 3944
  Complete submission text file 0001209191-21-018539.txt   12947
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GLYCOMIMETICS, INC. 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Feldman Eric Jay (Reporting) CIK: 0001848222 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 21722110